A Safety, Tolerability and Pharmacokinetic Study of CPP-115
NCT01493596
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Cocaine Dependency
Interventions
DRUG:
CPP-115
DRUG:
Placebo
Sponsor
Catalyst Pharmaceuticals, Inc.